Verastem, Inc. (VSTM)
Verastem, Inc. (VSTM)
$1.49 USD
Updated Jul 17 4:00pm
Add VSTM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
VSTM News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Verastem, Inc. (VSTM) Company Bio
Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts.
VSTM Stock Chart More Charts
VSTM Price/Volume Stats
| Current price | $1.49 |
| Prev. close | $1.54 |
| Day low | $1.47 |
| Day high | $1.54 |
| 50-day MA | $1.48 |
| 200-day MA | $3.32 |
| 52-week high | $10.35 |
| 52-week low | $1.16 |
| Volume | 913,500 |
| Avg. volume | 2,478,029 |
| Dividend yield | N/A |
| Market Cap | 110.08M |
VSTM Returns
| 1-mo | -18.13% |
| 3-mo | -31.34% |
| 6-mo | -56.94% |
| 1-year | -81.54% |
| 3-year | 12.03% |
| 5-year | -82.22% |
| YTD | -55.65% |
| 2018 | 9.45% |
| 2017 | 174.11% |
| 2016 | -39.78% |
| 2015 | -79.65% |
| 2014 | -19.82% |
Loading social stream, please wait...